Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Faron Pharmaceuticals Oy | LSE:FARN | London | Ordinary Share | FI4000153309 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
-7.00 | -2.48% | 275.00 | 270.00 | 280.00 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
282.00 | 275.00 | 282.00 | 12,944 | 09:02:08 |
Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0.0 | -28.7 | -48.0 | - | 174.62 |
Faron Pharmaceuticals Oy (FARN) News Headlines
Faron Pharmaceuticals Oy News
Date | Time | Source | Headline |
---|---|---|---|
24/4/2023 | 14:21 | ALNC | ![]() |
24/4/2023 | 07:00 | RNSNON | Faron Pharmaceuticals Oy Bexmarilimab Efficacy and Safety in MATINS Trial |
19/4/2023 | 07:00 | RNSNON | Faron Pharmaceuticals Oy Bexmarilimab KOL Event |
18/4/2023 | 07:00 | RNSNON | Faron Pharmaceuticals Oy Poster Presentations at AACR 2023 |
17/4/2023 | 16:34 | ALNC | ![]() |
17/4/2023 | 07:00 | UKREG | Faron Pharmaceuticals Oy BEXMAB study update |
13/4/2023 | 16:30 | RNSNON | Faron Pharmaceuticals Oy Faron at Canaccord Oncology Virtual Conference |
29/3/2023 | 10:42 | ALNC | ![]() |
29/3/2023 | 07:00 | UKREG | Faron Pharmaceuticals Oy Appointment of Chief Financial Officer |
24/3/2023 | 13:35 | UKREG | Faron Pharmaceuticals Oy Board Change |
1 Year Faron Pharmaceuticals Oy Chart |
Intraday Faron Pharmaceuticals Oy Chart |